PortViewPortView
ASLAN Pharmaceuticals Limited logo

ASLAN Pharmaceuticals Limited (ASLN) Stock Analysis

NASDAQHealthcareBiotechnology

$0.60-14.27%
1-year price historyRange $0.60 – $17.52
52-week range$0.60
$0.48$17.04

What ASLAN Pharmaceuticals Limited does

ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.

Key metrics

Market cap
$777.12M
P/E (TTM)
-0.04
EPS (TTM)
$-16.00
Beta
1.40
Dividend yield
0.00%
Revenue / share
$2.92
50-day avg
$1.07
200-day avg
$3.48
52-week high
$17.04
52-week low
$0.48
CEO
Carl Alan Jason Morton Firth EMBA,

ETFs linked to ASLN

Broad-market and Healthcare sector ETFs an investor holding ASLAN Pharmaceuticals Limited is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ASLN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ASLN in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited trades under the ticker ASLN on NASDAQ.
Which exchange is ASLN listed on?
ASLN is listed on NASDAQ.
What sector does ASLAN Pharmaceuticals Limited operate in?
ASLAN Pharmaceuticals Limited is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ASLN in a portfolio?
PortView shows ASLN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.